| References: |
P-glycoprotein (P-gp/ABCG1) inhibitor. Blocks P-gp-mediated multidrug resistance (MDR) of the cytotoxic drugs doxorubicin and vincristine in CHRC5 cells. Also inhibits breast cancer resistance protein (BCRP/ABCG2). Orally active. For the detailed information of Elacridar hydrochloride, the solubility of Elacridar hydrochloride in water, the solubility of Elacridar hydrochloride in DMSO, the solubility of Elacridar hydrochloride in PBS buffer, the animal experiment (test) of Elacridar hydrochloride, the cell expriment (test) of Elacridar hydrochloride, the in vivo, in vitro and clinical trial test of Elacridar hydrochloride, the EC50, IC50,and affinity,of Elacridar hydrochloride, For the detailed information of Elacridar hydrochloride, the solubility of Elacridar hydrochloride in water, the solubility of Elacridar hydrochloride in DMSO, the solubility of Elacridar hydrochloride in PBS buffer, the animal experiment (test) of Elacridar hydrochloride, the cell expriment (test) of Elacridar hydrochloride, the in vivo, in vitro and clinical trial test of Elacridar hydrochloride, the EC50, IC50,and affinity,of Elacridar hydrochloride, Please contact DC Chemicals. |
